ResMed Total Assets 2006-2018 | RMD

ResMed total assets from 2006 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • ResMed total assets for the quarter ending December 31, 2018 were $3.860B, a 8.3% increase year-over-year.
  • ResMed total assets for 2018 were $3.064B, a 11.66% decline from 2017.
  • ResMed total assets for 2017 were $3.468B, a 6.5% increase from 2016.
  • ResMed total assets for 2016 were $3.257B, a 49.27% increase from 2015.
ResMed Annual Total Assets
(Millions of US $)
2018 $3,064
2017 $3,468
2016 $3,257
2015 $2,182
2014 $2,361
2013 $2,211
2012 $2,138
2011 $2,069
2010 $1,626
2009 $1,508
2008 $1,406
2007 $1,252
2006 $1,013
2005 $774
ResMed Quarterly Total Assets
(Millions of US $)
Q2 2018 $3,860
Q1 2018 $3,068
Q4 2018 $3,064
Q3 2018 $3,534
Q2 2017 $3,564
Q1 2017 $3,490
Q4 2017 $3,468
Q3 2017 $3,423
Q2 2016 $3,323
Q1 2016 $3,322
Q4 2016 $3,257
Q3 2016 $2,445
Q2 2015 $2,239
Q1 2015 $2,255
Q4 2015 $2,182
Q3 2015 $2,278
Q2 2014 $2,327
Q1 2014 $2,309
Q4 2014 $2,361
Q3 2014 $2,365
Q2 2013 $2,346
Q1 2013 $2,335
Q4 2013 $2,211
Q3 2013 $2,375
Q2 2012 $2,330
Q1 2012 $2,245
Q4 2012 $2,138
Q3 2012 $2,129
Q2 2011 $2,041
Q1 2011 $1,935
Q4 2011 $2,069
Q3 2011 $1,962
Q2 2010 $1,884
Q1 2010 $1,792
Q4 2010 $1,626
Q3 2010 $1,713
Q2 2009 $1,621
Q1 2009 $1,620
Q4 2009 $1,508
Q3 2009 $1,326
Q2 2008 $1,307
Q1 2008 $1,293
Q4 2008 $1,406
Q3 2008 $1,366
Q2 2007 $1,319
Q1 2007 $1,288
Q4 2007 $1,252
Q3 2007 $1,192
Q2 2006 $1,132
Q1 2006 $1,031
Q4 2006 $1,013
Q3 2006 $899
Q2 2005 $860
Q1 2005 $816
Q4 2005 $774
Q3 2005 $674
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.218B $2.340B
ResMed Inc. is a world-leading connected health company with cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.838B 25.32
Medtronic (MDT) Ireland $112.952B 16.51
Stryker (SYK) United States $67.256B 24.66
Boston Scientific (BSX) United States $48.820B 23.72
Baxter (BAX) United States $37.991B 24.37
Zimmer Biomet Holdings (ZBH) United States $24.550B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $16.615B 0.00
Canopy Growth (CGC) Canada $14.912B 0.00
Aurora Cannabis (ACB) Canada $9.118B 64.29
Bio-Rad Laboratories (BIO) United States $8.765B 50.28
Perrigo (PRGO) Ireland $6.633B 10.75
Hill-Rom Holdings (HRC) United States $6.374B 19.72
Insulet (PODD) United States $4.900B 1642.60
GW Pharmaceuticals (GWPH) United Kingdom $4.701B 0.00
ICU Medical (ICUI) United States $4.568B 28.29
Haemonetics (HAE) United States $4.189B 37.16
Hutchison China MediTech (HCM) China $4.046B 0.00
Agios Pharmaceuticals (AGIO) United States $3.268B 0.00
Neogen (NEOG) United States $2.958B 48.10
NuVasive (NUVA) United States $2.784B 24.18
Quidel (QDEL) United States $2.365B 21.17
National Vision Holdings (EYE) United States $2.220B 43.66
Aphria (APHA) $1.917B 0.00
Phibro Animal Health (PAHC) United States $1.349B 19.38
VAREX IMAGING (VREX) United States $1.222B 23.93
Cardiovascular Systems (CSII) United States $1.190B 854.00
AtriCure (ATRC) United States $1.049B 0.00
Lantheus Holdings (LNTH) United States $0.931B 25.16
Omeros (OMER) United States $0.908B 0.00
PetIQ (PETQ) United States $0.862B 24.67
MacroGenics (MGNX) United States $0.791B 0.00
Cerus (CERS) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
TG Therapeutics (TGTX) United States $0.689B 0.00
Evolus (EOLS) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 22.66
OraSure Technologies (OSUR) United States $0.594B 25.86
Surmodics (SRDX) United States $0.546B 79.43
LeMaitre Vascular (LMAT) United States $0.536B 25.46
Meridian Bioscience (VIVO) United States $0.531B 15.82
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.88
Insys Therapeutics (INSY) United States $0.313B 0.00
BioLife Solutions (BLFS) United States $0.305B 125.85
Vapotherm (VAPO) United States $0.296B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Cytosorbents (CTSO) United States $0.219B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.171B 18.31
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.131B 0.00
Fonar (FONR) United States $0.125B 6.68
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
Female Health (VERU) United States $0.088B 0.00
United-Guardian (UG) United States $0.088B 20.06
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 13.71